Buparlisib: Phosphatidylinositol 3-kinase alpha inhibitor oncolytic

F. Azab, B. Muz, P. De La Puente, N. Salama, A. K. Azab

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)73-79
Number of pages7
JournalDrugs of the Future
Volume38
Issue number2
DOIs
StatePublished - Feb 2013

ASJC Scopus Subject Areas

  • Pharmacology
  • Pharmacology (medical)

Keywords

  • Buparlisib
  • NVP-BKM-120
  • Pan-PI3K inhibitor
  • PI3K signaling pathway
  • Treatment of cancer

Cite this